Weight loss treatments are about to explode — The names investors need to know

More than two-thirds of U.S. adults have obesity or are overweight. That means several weight loss drugs can be successful. A look at the landscape.

Related Keywords

Denmark ,United States ,American ,Danish ,Sciwind Biosciences ,Zealand Pharma ,Dylan Dupuis ,Eli Lilly ,Mark Purcell ,Trung Huynh ,Graig Suvannavejh ,Novo Nordisk Ozempic ,Jonathan Wolleben ,Chris Shibutani ,Terns Pharmaceuticals ,Astrazeneca ,American Diabetes Association ,Credit Suisse ,Pfizer ,Novo Nordisk ,Boehringer Ingelheim ,Morgan Stanley ,Goldman Sachs ,Drug Administration ,Citizens Company ,Shandong Suncadia Medicine ,Fujian Shengdi Pharmaceutical ,Mizuho Securities ,Viking Therapeutics ,Rani Therapeutics ,Quarterly Investment Guide Recession ,